Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5247
-0.0123 (-2.29%)
At close: May 12, 2025, 4:00 PM
0.5300
+0.0053 (1.01%)
After-hours: May 12, 2025, 6:26 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $45.21 million as of May 12, 2025. Its market cap has decreased by -76.48% in one year.
Market Cap
45.21M
Enterprise Value
-90.25M
1-Year Change
-76.48%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $45.21M, a decrease of -95.70%. That is a compound annual growth rate of -55.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 46.27M | -46.13% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |